Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Net Income (2016 - 2025)

OptimizeRx (OPRX) has disclosed Net Income for 16 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 6535.9% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2025, up 125.52% year-over-year, with the annual reading at $5.1 million for FY2025, 125.52% up from the prior year.
  • Net Income hit $5.0 million in Q4 2025 for OptimizeRx, up from $779000.0 in the prior quarter.
  • In the past five years, Net Income ranged from a high of $5.0 million in Q4 2025 to a low of -$11.7 million in Q4 2023.
  • Historically, Net Income has averaged -$2.6 million across 5 years, with a median of -$2.5 million in 2023.
  • Biggest five-year swings in Net Income: plummeted 8790.01% in 2022 and later skyrocketed 6535.9% in 2025.
  • Year by year, Net Income stood at $623462.0 in 2021, then plummeted by 152.26% to -$325836.0 in 2022, then crashed by 3503.04% to -$11.7 million in 2023, then soared by 99.34% to -$78000.0 in 2024, then surged by 6535.9% to $5.0 million in 2025.
  • Business Quant data shows Net Income for OPRX at $5.0 million in Q4 2025, $779000.0 in Q3 2025, and $1.5 million in Q2 2025.